{"timestamp": 1771594789.1184168, "value": {"ticker": "PMCB", "company_name": "PharmaCyte Biotech, Inc.", "short_name": "PharmaCyte  Biotech, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 7306729, "float_shares": 9358593, "shares_outstanding": 10134160, "short_ratio": 0.46, "short_percent_of_float": 0.0211, "shares_short": 179649, "shares_short_prior": 62893, "insider_percent_held": 0.08562, "institution_percent_held": 0.09712, "total_cash": 20607208, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 14.595, "book_value": 5.246, "price_to_book": 0.13743806, "operating_cashflow": -4523768, "free_cashflow": -7505044, "price": 0.721, "52w_high": 1.9, "52w_low": 0.63, "avg_volume": 3652965, "avg_volume_10d": 189340, "full_time_employees": 2, "audit_risk": 0, "overall_risk": 0}}